ISRCTN ISRCTN11821756
DOI https://doi.org/10.1186/ISRCTN11821756
IRAS number 334049
Secondary identifying numbers IRAS 334049
Submission date
18/06/2024
Registration date
04/07/2024
Last edited
12/11/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Plaque is microbial biofilms on surfaces such as teeth that can cause local inflammatory reactions and on a long-term, can lead to oral diseases. In routine clinical practice, dental professionals typically detect plaque by visual examination aided by a dental explorer. Plaque is generally colorless, and can be visualized by staining with a disclosing agent. DAs are special dyes that adhere to the biofilm and contrasts the plaque with color to the white tooth surface. When clinically assessing plaque, the assessment can be supported by using an index - many of these are, however, used more for research than in routine clinical practice.
The general routine clinical procedure for plaque detection has disadvantages such as lack of recording of clinical findings in images and dependency of examiner's skills.
Development of non-invasive techniques independent of human error to assist in plaque detection would have great benefit.
This study is about comparing current standard practice with plaque detection on different modality (3D scans).

Who can participate?
Any adult (over 18 years) can participate, as the study is involving a broad section of the population.

What does the study involve?
The patient will be checked to see if they meet the necessary conditions to be part of the study. They might have different amounts of plaque on their teeth. The dentist will then use special 3D scanning equipment, which is approved for dental use, to take detailed images of the inside of the patient's mouth. After that, the dentist will measure the amount of plaque using a standard method called the Silness & Löe index, which involves looking at the teeth and gums.

Next, the dentist will apply a special dye to the patient's teeth that makes the plaque visible by coloring it. The dentist will take another 3D scan of the teeth with the colored plaque and again measure the plaque using the Silness & Löe index.

In addition to examining the patient's teeth directly, the dentist will also measure the plaque by looking at the 3D scan images. One week later, the dentist will reassess the plaque using the same 3D scan images. Another dentist, who does not know the results of the previous examinations, will also evaluate the plaque on the 3D scan images.

What are the possible benefits and risks of participating?
The benefits of participating are that participants may discover a condition in their mouth they were otherwise unaware of. They will also potentially obtain a better understanding of the importance of good oral hygiene. The risks are that a small number of persons feel the scanner can be uncomfortable if it gets warm. There is also a very small risk that a participant is allergic to the disclosing agent without knowing in advance.

Where is the study run from?
Dental School at University of Bristol (UK)

When is the study starting and how long is it expected to run for?
January 2024 to March 2025

Who is funding the study?
The Danish medical device company, 3Shape

Who is the main contact?
Professor Nicola West, N.X.West@bristol.ac.uk

Contact information

Prof Nicola West
Public, Scientific, Principal Investigator

Lower Maudlin Street
Bristol
BS1 2LY
United Kingdom

Phone +44 (0)117 342 9638
Email N.X.West@bristol.ac.uk

Study information

Study designNon-randomized and non-interventional single-center cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)University/medical school/dental school
Study typeDiagnostic
Participant information sheet Not available in web format, please use contact details to request a participant information sheet.
Scientific titleInvestigating the utility of 3D-intraoral scan imaging to score plaque compared to clinical visual assessment
Study acronymNil known
Study hypothesisTo assess the accuracy of intraoral 3D scanner-derived detection by dichotomous outcome (yes/no) of plaque compared to the standard clinical visually-derived direct scoring of plaque.
Ethics approval(s)

Approved 10/06/2024, Yorkshhire & The Humber - Bradford Leeds Research Ethics Committee (Holland Drive, Newcastle upon Tyne, NE2 4NQ, United Kingdom; +44 2071048083; bradfordleeds.rec@hra.nhs.uk), ref: 334049

ConditionDental plaque in a variety amount present
InterventionThe patient will be screened according to the inclusion and exclusion criteria - they may have varying degrees of plaque. The clinician will then perform the 3D intraoral scan (using CE-marked equipment within its intended purpose), and the clinician will then perform a standard plaque indexing using the Silness & Löe index for visual examination. The patient will then get applied a disclosing agent to the teeth, colorizing the plaque. They will get another 3D scan of the disclosed teeth, and the dentist will perform the Silness & Löe plaque index on the disclosed teeth.
Without involving the patient, the clinician will also perform the plaque index examination directly on the scan. One week later, the clinician will score the plaque directly on the scan once more. Another clinician, blinded to the clinical truth, will also perform the plaque assessment on the scan.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Trios 5 intraoral scanner
Primary outcome measurePlaque measured using intraoral 3D scanner and standard clinical visually-derived direct scoring at baseline and 1 week
Secondary outcome measuresTo compare the performance of an algorithm detecting visible plaque to the clinical visual assessment of plaque and the 3D scan-derived assessment
Overall study start date02/01/2024
Overall study end date03/03/2025

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit100 Years
SexBoth
Target number of participants60
Participant inclusion criteria1. Participant is willing and able to give informed consent for participation in the study
2. Male or Female, adults aged 18 years or above
3. A minimum of 20 natural teeth present (10 teeth in each jaw)
4. Able (in the Investigators opinion) and willing to comply with all study requirements
Participant exclusion criteriaPresence of orthodontic brackets or clear aligner attachments
Recruitment start date27/06/2024
Recruitment end date11/11/2024

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Bristol
Senate House
Tyndall Avenue
Bristol
BS8 1TH
United Kingdom

Sponsor information

3Shape (Denmark)
Industry

Holmens Kanal 7
Copenhagen
1060
Denmark

Phone +45 30952141
Email josefine.jensen@3shape.com
Website https://www.3shape.com/
ROR logo "ROR" https://ror.org/042cmjn68

Funders

Funder type

Industry

3Shape A/S

No information available

Results and Publications

Intention to publish date18/10/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a peer-reviewed journal.
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available at a later date.

Editorial Notes

12/11/2024: The following changes were made to the trial record:
1. The secondary outcome measures were added.
2. The recruitment end date was changed from 03/01/2025 to 11/11/2024.
19/06/2024: Trial's existence confirmed by Yorkshhire & The Humber - Bradford Leeds Research Ethics Committee.